Rchr
J-GLOBAL ID:202301017445796369   Update date: Jan. 30, 2024

LIN JASON

リン ジェイソン | LIN JASON
Affiliation and department:
Job title: Staff Scientist
Research theme for competitive and other funds  (6):
  • 2023 - 2027 新世代in situ hybridization法の確立と多形肉腫の進化過程の解明
  • 2021 - 2025 深層学習による人工エピゲノム操作因子におけるゲノム干渉効果の評価及び予測
  • 2021 - 2024 Development of therapeutic strategy by eliminating mutant mitochondria for mitochondrial diseases
  • 2020 - 2022 Development of anticancer drugs targeting the mutated cancer genome
  • 2020 - 2021 Design, development and validation of ultra-sensitive detection platform for rare somatic genomic aberrations
Show all
Papers (30):
  • Jihang Yao, Keizo Takenaga, Nobuko Koshikawa, Yuki Kida, Jason Lin, Takayoshi Watanabe, Yoshiaki Maru, Yoshitaka Hippo, Seigi Yamamoto, Yuyan Zhu, et al. Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells. International Journal of Cancer. 2023. 152. 5. 962-976
  • Jason Lin, Shang-Chuen Wu. Implications of Transglutaminase-Mediated Protein Serotonylation in the Epigenetic Landscape, Small Cell Lung Cancer, and Beyond. Cancers. 2023. 15. 4. 1332-1332
  • Akiko Tsujimoto, Niina Matsuo, Xiaoyi Lai, Takahiro Inoue, Hiroyuki Yoda, Jason Lin, Yoshinao Shinozaki, Takayoshi Watanabe, Nobuko Koshikawa, Atsushi Takatori, et al. Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Cancer Medicine. 2022. 12. 5. 5821-5832
  • Takao Morinaga, Takashi Inozume, Masahito Kawazu, Youki Ueda, Nicolas Sax, Kazuo Yamashita, Shusuke Kawashima, Joji Nagasaki, Toshihide Ueno, Jason Lin, et al. Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration. Cancer Research Communications. 2022. 2. 7. 739-753
  • Yosuke Iwatate, Hajime Yokota, Isamu Hoshino, Fumitaka Ishige, Naoki Kuwayama, Makiko Itami, Yasukuni Mori, Satoshi Chiba, Hidehito Arimitsu, Hiroo Yanagibashi, et al. Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer. PLOS ONE. 2022. 17. 6. e0268630-e0268630
more...
MISC (1):
  • Hiroki Nagase, Kiriko Hiraoka, Takahiro Inoue, Hiroyuki Yoda, Krishnamurthy Sakthisri, Jason Lin, Takayoshi Watanabe, Nobuko Koshikawa, Atsushi Takatori. Mutated cancer cell-specific cell death activity of alkylating Pyrrole-Imidazole polyamide conjugates targeting a variety of oncogenic driver gene mutations. CANCER RESEARCH. 2016. 76
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page